2008
DOI: 10.1093/humrep/den246
|View full text |Cite
|
Sign up to set email alerts
|

Combating endometriosis by blocking proteasome and nuclear factor- B pathways

Abstract: PDTC and bortezomib may represent a novel therapeutic strategy for treatment of endometriosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
53
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(56 citation statements)
references
References 38 publications
3
53
0
Order By: Relevance
“…Upcoming experiments will study the interactions of the sperm proteasome with MFGE8, spermadhesins, and other acrosomal proteins that copurify with sperm proteasomes. In addition to the study of fertilization, the PSMA1-GFP pig model might be used to study a variety of reproductive technologies and disorders, such as germ cell transplantation (38), ovarian/oocyte function (39), and endometriosis (40). The transgenic animal model described in the present study is available through the National Institutes of Health-sponsored NSRRC and may be used to study the functioning of the UPS in a variety of cellular pathways and pathologies, such as Alzheimer's disease, Huntington disease, Parkinson disease, cancer, immune and inflammatory disorders, and liver cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…Upcoming experiments will study the interactions of the sperm proteasome with MFGE8, spermadhesins, and other acrosomal proteins that copurify with sperm proteasomes. In addition to the study of fertilization, the PSMA1-GFP pig model might be used to study a variety of reproductive technologies and disorders, such as germ cell transplantation (38), ovarian/oocyte function (39), and endometriosis (40). The transgenic animal model described in the present study is available through the National Institutes of Health-sponsored NSRRC and may be used to study the functioning of the UPS in a variety of cellular pathways and pathologies, such as Alzheimer's disease, Huntington disease, Parkinson disease, cancer, immune and inflammatory disorders, and liver cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…A study in p50 knockout mice showed a reduction in endometriotic implants size relative to endometriotic implants in wild type mice (84). Other animal studies have shown diminished endometriotic lesion development and cell proliferation in response to NFkB inhibition (71,80,85). In endometriotic cells in culture, inhibition of NF-kB reduced cell proliferation and stimulated apoptosis by down-regulating IL-8, macrophagemigration inhibitory factor, survivin, B-cell lymphoma/leukemia 2 (Bcl-2) and Bcl-XL (antiapoptotic proteins at the mitochondrial level), and by activating caspase 3, caspase 8, and caspase 9 (54,58,59,69,74,75).…”
Section: Nf-kb-regulated Cell Proliferation and Apoptosis In Endometrmentioning
confidence: 97%
“…Table 1 shows NF-kB-modulated genes (proteins) that have been shown to participate in endometriosis inflammatory reaction. Using NF-kB inhibitors in endometrial and endometriotic cell cultures and in endometriosis animal models has resulted in a reduction of the expression of most of the NF-kB-regulated cytokines mentioned in Table 1 (11,31,39,50,53,56,57,59,60,69,74,(77)(78)(79)(80)(81).…”
Section: Nf-kb-modulated Inflammation In Endometriosismentioning
confidence: 99%
“…It is believed that nuclear factor-kappa B (NF-kB) is a critical early regulator of the inflammatory response in endometriotic tissues (Celik et al 2008). Activation of NF-kB mediates cell proliferation and angiogenesis, which was observed through increases in the vascularized areas of newly-formed microvascular networks and the increased expression of cell proliferation markers in these endometriotic lesions (Wang et al 2005).…”
Section: Discussionmentioning
confidence: 99%